MedTrace Logo

Bezafibrate Trial in CPT2 Deficiency

NCT00336167 · Status: UNKNOWN · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 12

Last updated 2007-04-09

No results posted yet for this study

Summary

The purpose of this study is to determine whether bezafibrate is effective in the treatment of the muscular adult form of carnitine palmitoyltransferase 2 deficiency

Conditions

  • Carnitine Palmitoyl Transferase 2 Deficiency

Interventions

DRUG

bezafibrate (drug)

Sponsors & Collaborators

  • Association Française contre les Myopathies (AFM), Paris

    collaborator OTHER

  • Institut National de la Santé Et de la Recherche Médicale, France

    collaborator OTHER_GOV

  • Assistance Publique - Hôpitaux de Paris

    lead OTHER

Principal Investigators

  • Bruno EYMARD, M.D · Service de Neurologie 2 Groupe hospitalier Pitié-Salpétriere, Paris, France

  • Jean Paul BONNEFONT, M.D., Ph D, · Unite INSERM U781

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2006-06-30
Completion
2007-07-31

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00336167 on ClinicalTrials.gov